Skip to content
Open access · CC-BY via OpenAlex

The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus

Yue Wu, Wei Cui, Donghong Zhang, Wei Wu, Zhuo Yang

Oncotarget · 2017 · ▲ 33 citations

Abstract

// Yue Wu 1, 2 , Wei Cui 1, 2 , Donghong Zhang 3, 4 , Wei Wu 2 and Zhuo Yang 2 1 Department of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China 2 Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China 3 Department of Cardiology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, China 4 Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA Correspondence to: Wei Cui, email: [email protected] Donghong Zhang, email: [email protected] Keywords: type 2 diabetes mellitus, leukocyte telomere(definition) length, DNA methylation, LINE-1, glycated hemoglobin Received: April 04, 2017 Accepted: May 11, 2017 Published: May 22, 2017 ABSTRACT Background: We aim to investigate the cross-talking of leukocyte telomere length (LTL) and DNA methylation of LINE-1 in type 2 diabetes mellitus (T2DM). Results: LTL (ratio of the copy number of telomere [T] repeats to that of a single [S] gene) was significantly shortened in T2DM compared with controls (0.94 ± 0.41 vs. 1.14 ± 0.48, P < 0.001), and decreased steadily with age in both controls and T2DM. Conversely, significant increase of LINE-1 DNA methylation was found in T2DM compared with controls (49.60 ± 14.55 vs. 37.81 ± 9.07, P < 0.001). Moreover, age, HbA1c, and LINE-1 methylation ratio were stably negatively related with LTL after multi-adjustment. Shorter LTL was associated with an increased risk of T2DM [adjusted OR (95% CI) = 2.458 (1.192, 5.070), P = 0.015], while lower LINE-1 DNA methylation levels could reduce the risk of T2DM [adjusted OR (95% CI) = 0.189 (0.089, 0.400), P < 0.001]. Materials and Methods: We performed a hospital-based case–control study of 205 T2DM patients and 213 subjects of healthy control with sex and age matched. LTL and DNA methylation of LINE-1 was measured by quantitative PCR and quantitative methylation-specific PCR (qMSP), respectively. Conclusions: Our research demonstrates the association between shorter LTL and LINE-1 hyper-methylation in Chinese T2DM patients. These findings suggest that shorter LTL might be associated with T2DM in a manner dependent of epigenetic level.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/oncotarget.18167
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Wu, Y., Cui, W., Zhang, D., Wu, W., &amp; Yang, Z. (2017). The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus. <em>Oncotarget</em>. https://doi.org/10.18632/oncotarget.18167
Vancouver
Wu Y, Cui W, Zhang D, Wu W, Yang Z. The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus. Oncotarget. 2017. doi:10.18632/oncotarget.18167.
BibTeX
@article{yue2017Thesho, title = {The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus}, author = {Yue Wu and Wei Cui and Donghong Zhang and Wei Wu and Zhuo Yang}, journal = {Oncotarget}, year = {2017}, doi = {10.18632/oncotarget.18167}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings